PT - JOURNAL ARTICLE AU - Molnár, Dániel AU - Surányi, Éva Viola AU - Trombitás, Tamás AU - Füzesi, Dóra AU - Hirmondó, Rita AU - Tóth, Judit TI - Genetic Stability of <em>Mycobacterium smegmatis</em> under the Stress of First-Line Antitubercular Agents: Assessing Mutagenic Potential AID - 10.1101/2024.02.21.581394 DP - 2024 Jan 01 TA - bioRxiv PG - 2024.02.21.581394 4099 - http://biorxiv.org/content/early/2024/09/05/2024.02.21.581394.short 4100 - http://biorxiv.org/content/early/2024/09/05/2024.02.21.581394.full AB - The sustained success of Mycobacterium tuberculosis as a pathogen arises from its ability to persist within macrophages for extended periods and its limited responsiveness to antibiotics. Furthermore, the high incidence of resistance to the few available antituberculosis drugs is a significant concern, especially since the driving forces of the emergence of drug resistance are not clear. Drug-resistant strains of Mycobacterium tuberculosis can emerge through de novo mutations, however, mycobacterial mutation rates are low. To unravel the effects of antibiotic pressure on genome stability, we determined the genetic variability, phenotypic tolerance, DNA repair system activation, and dNTP pool upon treatment with current antibiotics using Mycobacterium smegmatis. Whole-genome sequencing revealed no significant increase in mutation rates after prolonged exposure to first-line antibiotics. However, the phenotypic fluctuation assay indicated rapid adaptation to antibiotics mediated by non-genetic factors. The upregulation of DNA repair genes, measured using qPCR, suggests that genomic integrity may be maintained through the activation of specific DNA repair pathways. Our results, indicating that antibiotic exposure does not result in de novo adaptive mutagenesis under laboratory conditions, do not lend support to the model suggesting antibiotic resistance development through drug pressure-induced microevolution.Competing Interest StatementThe authors have declared no competing interest.